ACR Appropriateness Criteria® Second and Third Trimester Screening for Fetal Anomaly.

AUC Appropriate Use Criteria Appropriateness Criteria Fetal MRI Fetal anomaly Fetal echocardiography Second trimester Soft markers Third trimester

Journal

Journal of the American College of Radiology : JACR
ISSN: 1558-349X
Titre abrégé: J Am Coll Radiol
Pays: United States
ID NLM: 101190326

Informations de publication

Date de publication:
May 2021
Historique:
received: 15 02 2021
accepted: 17 02 2021
entrez: 7 5 2021
pubmed: 8 5 2021
medline: 1 7 2021
Statut: ppublish

Résumé

The Appropriateness Criteria for the imaging screening of second and third trimester fetuses for anomalies are presented for fetuses that are low risk, high risk, have had soft markers detected on ultrasound, and have had major anomalies detected on ultrasound. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

Identifiants

pubmed: 33958112
pii: S1546-1440(21)00152-6
doi: 10.1016/j.jacr.2021.02.017
pii:
doi:

Types de publication

Practice Guideline Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S189-S198

Informations de copyright

Copyright © 2021 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Auteurs

Betsy L Sussman (BL)

The University of Vermont Medical Center, Burlington, Vermont. Electronic address: betsy.sussman@uvmhealth.org.

Prajna Chopra (P)

Research Author, The University of Vermont Medical Center, Burlington, Vermont.

Liina Poder (L)

Panel Chair, University of California San Francisco, San Francisco, California.

Dorothy I Bulas (DI)

Children's National Hospital and George Washington University, Washington, District of Columbia, Chair, ACR International Outreach Committee, Director, Fetal Imaging Prenatal Pediatric Institute, Childrens National Hospital.

Ingrid Burger (I)

Kaiser Permanente, Los Angeles, California.

Vickie A Feldstein (VA)

University of California San Francisco, San Francisco, California.

Sherelle L Laifer-Narin (SL)

Columbia University Medical Center, NY Presbyterian Hospital, New York, New York.

Edward R Oliver (ER)

Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Loretta M Strachowski (LM)

University of California San Francisco, San Francisco, California.

Eileen Y Wang (EY)

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, American College of Obstetricians and Gynecologists.

Tom Winter (T)

University of Utah, Salt Lake City, Utah.

Carolyn M Zelop (CM)

Valley Hospital, Ridgewood, New Jersey and NYU School of Medicine, New York, New York, American College of Obstetricians and Gynecologists.

Phyllis Glanc (P)

Specialty Chair, University of Toronto and Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH